Clinical Trials in Ibadan, Nigeria
10 recruiting
Showing 1–20 of 23 trials
Recruiting
Phase 3
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Sickle Cell DiseaseThalassemia
Novo Nordisk A/S480 enrolled105 locationsNCT06609226
Recruiting
Genetics of Type 2 Diabetes in West Africans
HypertensionDiabetes
National Human Genome Research Institute (NHGRI)10,000 enrolled5 locationsNCT00837122
Recruiting
Phase 2Phase 3
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Proteinuric Kidney Disease
Vertex Pharmaceuticals Incorporated466 enrolled318 locationsNCT05312879
Recruiting
Not Applicable
Change My Story Task Shifted Mental Health Intervention
Psychological DistressDepressionHIV
Massachusetts General Hospital80 enrolled1 locationNCT06389565
Recruiting
Phase 2
MicroRNA Profiles in Triple Negative Breast Cancer
Triple-Negative Breast Cancer
University College Hospital, Ibadan42 enrolled4 locationsNCT04771871
Recruiting
Phase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sickle Cell Disease
Novo Nordisk A/S408 enrolled172 locationsNCT06612268
Recruiting
Not Applicable
Combination Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria
HIV
Northwestern University100 enrolled1 locationNCT06190613
Recruiting
Phase 2Phase 3
A Phase 2/3 Study in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Pfizer389 enrolled49 locationsNCT05431088
Recruiting
Phase 2
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
Triple-Negative Breast Cancer
University of Chicago85 enrolled4 locationsNCT06291064
Recruiting
Phase 2
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Breast CancerHER2-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
University of Chicago74 enrolled4 locationsNCT06348134
Recruiting
Health Systems and Policy Contexts of Medical Oxygen
PneumoniaMoralityHypoxemia
Murdoch Childrens Research Institute1 enrolled6 locationsNCT06169514
Recruiting
Phase 1
Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Pediatric HIV InfectionTuberculosis Infection
Brigham and Women's Hospital20 enrolled1 locationNCT05069688
Recruiting
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
Breast CancerBreast Cancer Female
Memorial Sloan Kettering Cancer Center900 enrolled8 locationsNCT05561842
Recruiting
Phase 2
ATORvastatin in Pulmonary TUBerculosis
TuberculosisPulmonary TuberculosisKoch's Disease
Obafemi Awolowo University Teaching Hospital440 enrolled8 locationsNCT06199921
Recruiting
Phase 2
A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
Sickle Cell Disease
Forma Therapeutics, Inc.27 enrolled9 locationsNCT05953584
Recruiting
Phase 3
Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
HIV Disease Progression
Population Health Research Institute8,000 enrolled52 locationsNCT05580666
Recruiting
Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria
Cervical CancerHIV
Emory University1,500 enrolled3 locationsNCT06751030
Recruiting
Phase 4
Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT
Monkeypox
McMaster University3,000 enrolled10 locationsNCT05745987
Recruiting
Evaluation of a Multi-country Medical Oxygen Program
SepsisPneumoniaMorality+2 more
Murdoch Childrens Research Institute1,200 enrolled3 locationsNCT06087315
Recruiting
Phase 3
Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
Surgical wound infectionAnesthesiaPathologic Processes+9 more
University of Birmingham12,942 enrolled37 locationsNCT04256798